BR9915835A - Composição farmacêutica, e, processo para a preparação de uma composição - Google Patents
Composição farmacêutica, e, processo para a preparação de uma composiçãoInfo
- Publication number
- BR9915835A BR9915835A BR9915835-3A BR9915835A BR9915835A BR 9915835 A BR9915835 A BR 9915835A BR 9915835 A BR9915835 A BR 9915835A BR 9915835 A BR9915835 A BR 9915835A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- preparation
- pharmaceutical composition
- methyl
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSIçãO FARMACêUTICA, E, PROCESSO PARA A PREPARAçãO DE UMA COMPOSIçãO" A presente invenção fornece uma nova composição farmacêutica contendo 5-[[4-[3-metil-4-oxo-3,4-diidro-2-quinazolinil]metoxi]fenil-metil] tiadiazolidina-2,4-diona como ingrediente ativo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199801580 | 1998-12-01 | ||
PCT/DK1999/000663 WO2000032191A1 (en) | 1998-12-01 | 1999-11-29 | New pharmaceutical composition and the process for its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9915835A true BR9915835A (pt) | 2001-08-21 |
Family
ID=8106261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9915835-3A BR9915835A (pt) | 1998-12-01 | 1999-11-29 | Composição farmacêutica, e, processo para a preparação de uma composição |
Country Status (21)
Country | Link |
---|---|
US (1) | US7439248B1 (pt) |
EP (1) | EP1135127B1 (pt) |
JP (2) | JP5524435B2 (pt) |
KR (1) | KR100690311B1 (pt) |
CN (1) | CN1158075C (pt) |
AT (1) | ATE316376T1 (pt) |
AU (1) | AU776299B2 (pt) |
BR (1) | BR9915835A (pt) |
CA (1) | CA2352430C (pt) |
CZ (1) | CZ300543B6 (pt) |
DE (1) | DE69929635T2 (pt) |
ES (1) | ES2257886T3 (pt) |
HU (1) | HUP0104544A3 (pt) |
IL (3) | IL143299A0 (pt) |
NO (1) | NO329909B1 (pt) |
PL (1) | PL197077B1 (pt) |
RU (1) | RU2233659C2 (pt) |
TW (1) | TWI235657B (pt) |
UA (1) | UA75569C2 (pt) |
WO (1) | WO2000032191A1 (pt) |
ZA (1) | ZA200104261B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5524435B2 (ja) * | 1998-12-01 | 2014-06-18 | ドクター レディーズ ラボラトリーズ リミティド | 新規医薬組成物及びその調製のための方法 |
US20010047032A1 (en) * | 1999-12-30 | 2001-11-29 | Castillo Gerardo M. | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
AU2001260083A1 (en) * | 2000-05-26 | 2001-12-03 | Dr. Reddy's Research Foundation | New pharmaceutical composition and the process for its preparation |
AU2000249111A1 (en) * | 2000-05-30 | 2001-12-11 | Dr. Reddy's Research Foundation | New pharmaceutical composition and the process for its preparation |
US20050118202A1 (en) * | 2001-12-19 | 2005-06-02 | Akio Yamashita | Solid compositions containing compounds unstable to oxygen and method for stabilization thereof |
WO2006002255A2 (en) * | 2004-06-23 | 2006-01-05 | Dr. Reddy's Laboratories Ltd. | A pharmaceutical formulation of balaglitazone |
CL2008000596A1 (es) * | 2007-03-01 | 2008-09-05 | Glaxo Group Ltd | Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas. |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4280997A (en) * | 1978-12-08 | 1981-07-28 | Johannes Van Leverink | Extrusion process for the preparation of anhydrous stable lactose |
DE3433239A1 (de) * | 1984-09-11 | 1986-03-20 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung |
CA2019324C (en) * | 1989-07-10 | 1996-08-20 | Robert L. Jerzewski | Fosinopril tablet formulations |
IT1238072B (it) * | 1990-01-19 | 1993-07-03 | Sclavo Spa | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina |
EP0578732B1 (en) * | 1991-04-04 | 1996-06-19 | The Procter & Gamble Company | Chewable antacid compositions |
CZ227093A3 (en) * | 1991-04-29 | 1994-03-16 | Merck & Co Inc | Mixture suitable for the preparation of tablets by direct moulding |
TW268952B (pt) * | 1993-02-26 | 1996-01-21 | Takeda Pharm Industry Co Ltd | |
CN1133005A (zh) * | 1993-09-03 | 1996-10-09 | 史密丝克莱恩比彻姆公司 | 稳定的片剂 |
US5532256A (en) | 1994-05-18 | 1996-07-02 | American Home Products Corporation | New azolidinediones and thiadiazolidinediones as antihyperglycemic agents |
ES2079327B1 (es) * | 1994-12-13 | 1996-08-01 | Lilly Sa | Formulaciones farmaceuticas de cefaclor. |
AU4353996A (en) * | 1994-12-14 | 1996-07-03 | Bioglan Ireland (R & D) Limited | Pharmaceutical tablet formulations for direct compression |
US6395303B1 (en) * | 1996-06-10 | 2002-05-28 | Edward Mendell Co., Inc. | Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose |
JPH09249561A (ja) * | 1996-03-15 | 1997-09-22 | Teikoku Chem Ind Corp Ltd | 医薬組成物 |
HU222109B1 (hu) * | 1996-09-10 | 2003-04-28 | EGIS Gyógyszergyár Rt. | Captopriltartalmú tabletták és eljárás ezek előállítására |
PT958296E (pt) * | 1996-12-31 | 2003-11-28 | Reddys Lab Ltd Dr | Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas |
WO1998045291A1 (en) | 1997-12-02 | 1998-10-15 | Dr. Reddy's Research Foundation | Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties |
EP0945134A1 (de) * | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation |
JP5524435B2 (ja) * | 1998-12-01 | 2014-06-18 | ドクター レディーズ ラボラトリーズ リミティド | 新規医薬組成物及びその調製のための方法 |
AU2001260083A1 (en) * | 2000-05-26 | 2001-12-03 | Dr. Reddy's Research Foundation | New pharmaceutical composition and the process for its preparation |
WO2006002255A2 (en) | 2004-06-23 | 2006-01-05 | Dr. Reddy's Laboratories Ltd. | A pharmaceutical formulation of balaglitazone |
-
1999
- 1999-11-29 JP JP2000584886A patent/JP5524435B2/ja not_active Expired - Fee Related
- 1999-11-29 AU AU13762/00A patent/AU776299B2/en not_active Ceased
- 1999-11-29 CZ CZ20011832A patent/CZ300543B6/cs not_active IP Right Cessation
- 1999-11-29 RU RU2001117850/15A patent/RU2233659C2/ru not_active IP Right Cessation
- 1999-11-29 KR KR1020017006782A patent/KR100690311B1/ko not_active IP Right Cessation
- 1999-11-29 ES ES99972919T patent/ES2257886T3/es not_active Expired - Lifetime
- 1999-11-29 AT AT99972919T patent/ATE316376T1/de not_active IP Right Cessation
- 1999-11-29 DE DE69929635T patent/DE69929635T2/de not_active Expired - Lifetime
- 1999-11-29 HU HU0104544A patent/HUP0104544A3/hu unknown
- 1999-11-29 BR BR9915835-3A patent/BR9915835A/pt not_active Application Discontinuation
- 1999-11-29 IL IL14329999A patent/IL143299A0/xx active IP Right Grant
- 1999-11-29 CA CA002352430A patent/CA2352430C/en not_active Expired - Fee Related
- 1999-11-29 CN CNB99813970XA patent/CN1158075C/zh not_active Expired - Fee Related
- 1999-11-29 WO PCT/DK1999/000663 patent/WO2000032191A1/en active Application Filing
- 1999-11-29 PL PL348601A patent/PL197077B1/pl unknown
- 1999-11-29 EP EP99972919A patent/EP1135127B1/en not_active Expired - Lifetime
- 1999-11-29 UA UA2001053674A patent/UA75569C2/uk unknown
- 1999-11-30 US US09/450,609 patent/US7439248B1/en not_active Expired - Fee Related
- 1999-12-27 TW TW088123261A patent/TWI235657B/zh not_active IP Right Cessation
-
2001
- 2001-05-22 IL IL143299A patent/IL143299A/en not_active IP Right Cessation
- 2001-05-24 ZA ZA200104261A patent/ZA200104261B/en unknown
- 2001-05-31 NO NO20012673A patent/NO329909B1/no not_active IP Right Cessation
-
2006
- 2006-12-05 IL IL179865A patent/IL179865A/en not_active IP Right Cessation
-
2012
- 2012-04-06 JP JP2012087678A patent/JP2012144560A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1036931A1 (en) | Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients. | |
BR9810829B1 (pt) | composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica. | |
BR9913255A (pt) | Composto, composição farmacêutica, processo de tratamento de uma condição de doença mediada por metaloproteinase, processo para preparar um composto, e, uso de um composto | |
BR0116402A (pt) | Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular | |
EE200100594A (et) | Uudsed ravimikompositsioonid, mis põhinevad antikolinergiliselt toimivatel ühenditel ja ß-mimeetikumidel | |
BRPI0215312B8 (pt) | composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
BR9811022A (pt) | Composto, composição farmacêutica, e, processo para preparação de um composto | |
DE69925133D1 (de) | Pyrrolobenzodiazepine | |
EE04799B1 (et) | Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
PT956858E (pt) | Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais | |
BR0015605A (pt) | Composição e uso | |
BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
MXPA02002249A (es) | Composiciones farmaceuticas agradables al paladar para animales de compania. | |
BR0008753B1 (pt) | Composto de amida, processo para preparar um composto de amida, composição farmacêutica e uso de um composto de amida | |
BR9812492A (pt) | Composto, uso do mesmo, formulação farmacêutica, e, processos para o tratamento de uma doença cardiovascular, para o tratamento de uma vasoconstrição, e para a preparação de compostos | |
BR9713338A (pt) | Benzonaftiridinas como terapêuticos brÈnquicos. | |
GEP20002332B (en) | Cefalosporin Derivatives | |
BR0111678A (pt) | Composições medicinais contendo derivados de propenona | |
BR0215027A (pt) | Derivados de 6-aminomorfinano, processo de preparação para o mesmo e sua aplicação | |
RS50046B (sr) | Farmaceutske kompozicije tizoksanida i nitazoksanida | |
BR9915835A (pt) | Composição farmacêutica, e, processo para a preparação de uma composição | |
DE60129829D1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
EA199901012A1 (ru) | Фармацевтические композиции на основе тизоксанида и нитазоксанида | |
ES2192789T3 (es) | Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios. | |
RS50033B (sr) | Derivati etansulfonil-piperidina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: DR. REDDY S LABORATORIES, INC. (US) , DR. REDDY S Free format text: TRANSFERIDO DE: NOVO NORDISK A/S E DR. REDDY S RESEARCH FOUNDATION |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO ATENDE AOS REQUISITOS DE PATENTEABILIDADE CONFORME O DISPOSTO NOS ARTGOS 8O COMBINADO COM O 13 DA LEI 9.279/96. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] |